Ann C. Miller's most recent trade in Inovio Pharmaceuticals Inc was a trade of 41,800 Common Stock Options done . Disclosure was reported to the exchange on May 20, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Inovio Pharma Inc | Ann C. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2026 | 41,800 | 41,800 | - | - | Common Stock Options | |
| Inovio Pharma Inc | Ann C. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2026 | 34,200 | 34,200 | - | - | Restricted Stock Unit | |
| Inovio Pharma Inc | Ann C. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 2,167 | 9,877 (0%) | 0% | - | Common Stock | |
| Inovio Pharma Inc | Ann C. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 2,167 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharma Inc | Ann C. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 2,917 | 2,917 | - | - | Common Stock Options | |
| Inovio Pharma Inc | Ann C. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 2,167 | 2,167 | - | - | Restricted Stock Unit | |
| Inovio Pharma Inc | Ann C. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,166 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharma Inc | Ann C. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,166 | 7,710 (0%) | 0% | - | Common Stock | |
| Inovio Pharma Inc | Ann C. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 35,000 | 35,000 | - | - | Common Stock Options | |
| Inovio Pharma Inc | Ann C. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 26,000 | 26,000 | - | - | Restricted Stock Unit | |
| Inovio Pharma Inc | Ann C. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 19,000 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharma Inc | Ann C. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 19,000 | 66,534 (0%) | 0% | - | Common Stock | |
| Inovio Pharma Inc | Ann C. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 28,000 | 28,000 | - | - | Common Stock Options | |
| Inovio Pharma Inc | Ann C. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 19,000 | 19,000 | - | - | Restricted Stock Unit | |
| Inovio Pharma Inc | Ann C. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2022 | 18,000 | 47,534 (0%) | 0% | - | Common Stock | |
| Inovio Pharma Inc | Ann C. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2022 | 18,000 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharma Inc | Ann C. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2022 | 4,273 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharma Inc | Ann C. Miller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2022 | 4,273 | 29,534 (0%) | 0% | - | Common Stock |